Search results for: 'injection diseas in the developing world'

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

European economies had a challenging 2022 due to the onset of the Russo-Ukrainian War and the heightened inflationary pressure. The war impacted national security and weighed heavily on regional companies' economic performance. Historic price levels mandated monetary policy tightening as energy and fuel prices reduced consumer spending. Moreover, r...

27 Oct 2021  |  Asia Pacific  |  Frost Radar

Frost Radar™ for Economic Development: Broader Asia, 2021

Australia, South Korea, and New Zealand Emerge as the Broader Asian Leaders

Infographics

×

Key Issues Addressed

The Frost Radar™ for Economic Development determines a region's future growth and development potential measured by its ability to enhance citizen satisfaction of quality of life. This report explores Broader Asia’s strengths and weaknesses through country-level assessments of growth and innovation initiatives and benchmarks each country on these t...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) encompasses insights across advances in targeted neurological therapies, cancer treatments, and AI-powered drug development. The TOE also features innovators for treatment of metabolic diseases such as obesity and heart failure.The Life Science, Health & Wellnes...

At present, only a few therapies are available with relatively low success. Both, the clinical and the scientific communities are critically devoted to develop new therapeutic approaches to treat and diagnose neurodegenerative diseases. At present days, neurodegenerative diseases represent one of the main causes of death in the industrialized econ...

At present, only a few therapies are available with relatively low success. Both, the clinical and the scientific communities are critically devoted to develop new therapeutic approaches to treat and diagnose neurodegenerative diseases. At present days, neurodegenerative diseases represent one of the main causes of death in the industrialized econ...

The COVID-19 pandemic prompted a transformation in the infectious disease point-of-care testing (POCT) market. The shift towards miniaturized POCT devices will lead to the emergence of cost-effective integrated lab-on-a-chip devices based on microfluidic technologies and smartphone-based solutions enabling multiplexed detection of infectious pathog...

Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and genetic diseases. More than 80% of rare diseases are genetic in origin, so that gene and cell therapies are being...

03 Oct 2022  |  Global  |  Technology Research

No Code: The Future of Software Development Process

No-code Platforms Will Disrupt the Way Enterprises Develop Their Applications.

Infographics

×

As enterprises emerge from the COVID-19 pandemic, many are still struggling to completely resume operations, such as streamlining workflows, improving employee productivity, and enhancing customer experience, in an operating environment that is vastly different from what it was 2 years ago. Enterprises’ teams are more geographically dispersed than ...